LENVATINIB for Papillary thyroid cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 501 adverse event reports in the FDA FAERS database where LENVATINIB was used for Papillary thyroid cancer.

Most Reported Side Effects for LENVATINIB

Side Effect	Reports	%	Deaths	Hosp.
Diarrhoea	4,262	12.6%	321	2,714
Hypertension	4,152	12.3%	405	2,522
Fatigue	3,603	10.7%	208	2,023
Decreased appetite	3,257	9.7%	363	2,209
Malignant neoplasm progression	2,929	8.7%	1,549	1,298
Nausea	2,492	7.4%	160	1,637
Blood pressure increased	2,228	6.6%	104	1,411
Vomiting	1,962	5.8%	122	1,458
Asthenia	1,643	4.9%	122	1,180
Malaise	1,602	4.7%	241	989
Weight decreased	1,529	4.5%	106	901
Dehydration	1,526	4.5%	97	1,375
Pyrexia	1,438	4.3%	134	1,149
Hypothyroidism	1,375	4.1%	165	698
Headache	1,268	3.8%	50	810